Earnings Scheduled For May 14, 2026
MBX Biosciences Inc MBX
$31.43
▲ +3.42%
(+$1.04)
Open
$30.75
Prev Close
$30.39
Day Range
$30.35 – $31.86
52W Range
$9.43 – $45.85
Market Cap
$1.50B
Beta
1.65
EPS (TTM)
$-2.21
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2024-09-13 |
| Shares Out. | 47,600,000 |
| Website | mbxbio.com/ ↗ |
| Phone | 13179893100 |
MBX Biosciences Inc is a publicly traded company under the ticker symbol MBX on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
15 analysts (2026-05-01)
📰 Latest News for MBX
Barclays Maintains Overweight on MBX Biosciences, Raises Price Target to $70
Citizens Maintains Market Outperform on MBX Biosciences, Raises Price Target to $86
MBX Biosciences, Inc. (MBX) Discusses Novel Approaches and Clinical Progress in Obesity Therapeutics Portfolio - Slideshow
MBX Biosciences, Inc. (MBX) Discusses Novel Approaches and Clinical Progress in Obesity Therapeutics Portfolio Transcript
Transcript : MBX Biosciences, Inc. - Special Call
Truist Securities Maintains Buy on MBX Biosciences, Raises Price Target to $70
MBX Biosciences : May 2026 Obesity Day Presentation – Final